TrialKey is revolutionising clinical trials through AI-driven solutions designed to optimise trial designs, predict outcomes, and address key healthcare challenges. Our mission is to streamline clinical research, accelerate medical advancements, and improve patient outcomes using AI to enhance efficiency and accuracy.

TrialKey’s team combines expertise in regulatory affairs, clinical research, pharmacogenetics, precision medicine, clinical trial design, biostatistics, clinical operations, patient care, clinical pharmacology, drug safety, nutrition, and medical research. This diverse knowledge allows us to create tailored solutions that optimise clinical trial processes from design to execution, ensuring efficiency and regulatory alignment. Our senior leadership has decades of experience in AI, technology commercialisation, and clinical research, keeping TrialKey at the forefront of clinical trial optimisation. With expertise in machine learning, predictive analytics, and regulatory affairs, our leadership drives the scaling of innovative solutions that accelerate clinical trials and improve outcomes.

Strategic partnerships are central to our success. Collaborating with leaders like Commercial Eyes, Biointelect, Alithia Life Sciences, Southern Clinical Development Consulting, Phenix Health, L39 Capital, NeuOrphan, and Avion Medical, we leverage collective expertise to deliver data-driven solutions. These partnerships enable us to optimise trial designs, improve patient recruitment, and execute smarter, faster trials, leading to quicker market access for life-saving treatments.

Why work with us

TrialKey is an AI Agent automating processes with AI to improve efficiency and enhance result accuracy. As the global leader in AI-driven biostatistical validation, TrialKey’s advanced simulators analyse real-world data and generates optimised clinical trial designs. Our platform draws on an extensive dataset of over 468,000 trials, covering more than 114,000 conditions and insights from 2.69 billion patients. By analysing 1,300 variables per trial, TrialKey offers actionable insights that optimise patient recruitment, refine inclusion and exclusion criteria, determine ideal site locations, and enhance study arm structures. These innovations reduce trial timelines, improve outcomes, and conserve resources.

Our Services:

• • Predict Outcomes: Advanced analytics and real-world data allow TrialKey to accurately forecast trial results, helping researchers minimise risks and make informed decisions.
  • Optimise Trials: We enhance ongoing trials by adjusting key parameters such as patient touchpoints, site distribution, and study duration to improve efficiency and outcomes.

Create Trial Designs: TrialKey leverages AI to design trials with the highest probability of success from the outset, ensuring precision and regulatory alignment.

TrialKey partners with contract research organisations, pharmaceutical companies, and biotech innovators to revolutionise clinical research. Through AI-driven insights and tailored solutions, we help create faster, more efficient, and patient-centered trials.